Is U.S. Health Care More Expensive?

In a 1999 paper on international drug price comparisons, Patricia M. Danzon and Michael F. Furukawa illustrate how much the choice of currency conversion method matters. U.S. drugs are less expensive than all countries but France if a health purchasing power parity basket is used to convert. They are more expensive than in most other […]



via John Goodman's Health Policy Blog http://ift.tt/1memcnE